跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 7,051 条关于
“Windward Bio AG”
全部
7,051
临床试验
2,791
药物
1,393
机构
553
资讯
2,314
去年
HBM Holdings Secures NMPA Approval to Begin COPD Drug Trials in China
9个月前
Windward Bio Secures $700M Licensing Deal for Dual-Target Bispecific Antibody WIN027
去年
Windward Bio Secures Global License for Anti-TSLP Antibody SKB378/HBM9378 in $970M Deal
去年
Long-Acting Anti-TSLP Antibody HBM9378/WIN378 Enters Global Phase 2 Trial for Asthma Treatment
去年
Windward Bio Launches with $200 Million to Advance Long-Acting Anti-TSLP Antibody for Asthma and COPD
3年前
Novo Holdings Leads $200M Series A Investment in Windward Bio for Advanced Respiratory Treatments
4个月前
Windward Bio Secures $165M to Advance Ultra Long-Acting Immunology Therapies for Asthma and COPD
9天前
Kelun-Biotech and Windward Bio Report Positive Phase 2 Interim Data for Twice-Yearly Asthma Antibody SKB378/WIN378
去年
Bio Usawa and Bioeq AG Partner to Bring Ranibizumab Biosimilar to Sub-Saharan Africa
去年
Foresee Pharmaceuticals Initiates Phase 2 WINDWARD Trial of Mirivadelgat for PH-ILD Treatment
第 1 页,共 232 页
上一页
下一页